Jefferies upgraded MetLife from Hold to Buy and set a new price target of $72.00 from $58.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $97.00 | Market Perform | BMO Capital Markets |
| 10/9/2024 | $97.00 | Buy | TD Cowen |
| 9/5/2024 | $91.00 | Overweight | Barclays |
| 1/8/2024 | $80.00 | Neutral → Buy | Goldman |
| 11/17/2023 | $71.00 | Overweight | Barclays |
| 10/5/2023 | $71.00 | Hold | Deutsche Bank |
| 9/14/2023 | $58.00 → $72.00 | Hold → Buy | Jefferies |
| 1/9/2023 | $80.00 → $78.00 | Buy → Neutral | Goldman |
BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00
TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00
Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest
MetLife, Inc. (NYSE:MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, will participate in a fireside chat at the 2025 Keefe, Bruyette & Woods Annual Insurance Conference on Wednesday, Sept. 3, 2025, from 10:05 a.m. to 10:45 a.m. (ET). A live audio webcast of the presentation will be available at https://event.summitcast.com/view/K8Qj6Ho6wvLLfFK2h5DE7w/n8bgBuwQnmybd6vjVT2Jmi. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation
LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The 2025 Pet Innovation Awards today announced that MetLife Pet Insurance (MetLife) has been selected as "Pet Insurance of the Year" in the 7th Annual Awards Program. The Pet Innovation Awards is an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet Care industry. Pet owners are investing more in preventive health measures and MetLife offers the protection needed for all stages of a pet's life, including an optional preventive care coverage add-on. This add-on features coverage for flea and tick control, spay/neuter, heartworm prevention, teeth cleaning, vaccinat
8-K - METLIFE INC (0001099219) (Filer)
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest
MetLife, Inc. (NYSE:MET) today announced its second quarter 2025 results. Earnings Return Per Share on Equity (ROE) 2Q 2025 2Q 2025 Net Income $1.03 ROE 11.7% Adjusted Earnings $2.02 Adjusted ROE 14.6% Net income was $698 million. Adjusted earnings declined to $1.4 billion, due to less favorable underwriting and lower investment margins, partially offset by volume growth and favorable expense margins. Premiums, fees and other revenues (PFOs) were $12.7 billion. Adjusted
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a second quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806874930/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and i
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi
MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh
Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such